Skip to content

OBOS Post: More Controversy Surrounding Merck and Vioxx

April 17, 2008

Yesterday at Our Bodies Our Blog, I posted a brief overview of the new debate about possible ghostwriting and data manipulation surrounding Merck and Vioxx, stemming from publications in the current issue of JAMA. Links to the freely available full-text investigations are provided, as is a timeline of Vioxx from approval to market withdrawal and beyond.

No comments yet

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: